Victrex Total Current Liabilities 2019-2024 | VTXPF
Victrex total current liabilities from 2019 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Victrex Annual Total Current Liabilities
(Millions of US $) |
| 2024 |
$58 |
| 2023 |
$56 |
| 2022 |
$108 |
| 2021 |
$77 |
| 2020 |
$48 |
| 2019 |
$68 |
| 2018 |
$69 |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
Victrex Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$58 |
| 2023-09-30 |
$56 |
| 2023-03-31 |
$81 |
| 2022-09-30 |
$108 |
| 2022-03-31 |
$77 |
| 2021-09-30 |
$77 |
| 2021-03-31 |
$54 |
| 2020-09-30 |
$48 |
| 2020-03-31 |
$61 |
| 2019-09-30 |
$68 |
| 2019-03-31 |
$55 |
| 2018-09-30 |
$69 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Plastics |
$1.092B |
$0.369B |
|
Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom.
|
